(Q34693403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

J Parini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M Romano

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A Libretti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

135-138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

Atenolol and chlorthalidone in combination for hypertension

6 October 2019

cites work

1 reference

12 December 2020

3-Hydrazinepyridazine derivatives. III. Synthesis and anti-hypertensive activity of new 3-(2-acylhydrazine)-pyridazine-6-alkylamino substitutes

1 reference

12 December 2020

Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.

1 reference

12 December 2020

Vasodilator drugs in the treatment of hypertension

1 reference

12 December 2020

Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension

1 reference

12 December 2020

When to use oral vasodilators for hypertension

1 reference

12 December 2020

Cadralazine (ISF 2469): dose-related antihypertensive activity after single oral administration to patients.

1 reference

12 December 2020

Comparison of the antihypertensive activity of cadralazine (ISF 2469) and dihydralazine during chronic treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00609680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3886402%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 October 2019

1034838476

0 references

Fatcat ID

release_52egymqe7fgdjfkgyc3pxrxp5e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/52egymqe7fgdjfkgyc3pxrxp5e

24 November 2022

mapped directly with Wikidata item

1 reference